We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

First Meeting of Nanomedicine Society

By Biotechdaily staff writers
Posted on 24 Aug 2005
The American Academy of Nanomedicine (AANM, Washington, DC, USA) held its first annual meeting at Johns Hopkins University (Baltimore, MD, USA) on August 15 and 16, 2005.

Founded in early 2005, the AANM is an international society created to advance both clinical applications and research in the field of nanomedicine. The two-day program focused on the applications of nanomedicine in a variety of fields including diagnostic, clinical, oncology, pharmacology, basic and experimental nanomedicine, and the policy and commercialization of nanomedicine.

The keynote speaker was James Baker, Jr., M.D., from the Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan (Ann Arbor, USA), who lectured on "What is Nanomedicine?” He further described how nanoscale synthetic materials with biologic systems provide both great promises and risks for biologic sciences.

The second address was given by Dr. Ueli Aebi from the U.S. National Center of Competence in Research, Mueller Institute (Basel, Switzerland), in a lecture entitled "Imaging, Measuring, and Manipulating Living Matter by Minimally Invasive Nanoprobes.”

AANM's membership represents basic and clinical investigators, molecular biologists, engineers, physicians, and others with an interest in the field. It is the only society devoted specifically to the emerging field of nanomedicine. The Academy's first meeting provided a forum to exchange ideas, communicate new findings, and encouraged collaboration among the diverse disciplines represented in nanomedicine.




Related Links:
American Academy of Nanomedicine

New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Clinical Informatics Platform
CLARION™
New
Automatic CLIA Analyzer
Shine i6000

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
24 Aug 2005  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
24 Aug 2005  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
24 Aug 2005  |   BioResearch